Minor
NТО-RAS · Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory · RAS Mutations
Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Recruiting
N.N. Petrov National Medical Research Center of OncologyPhase 2 NCT06229340 Registry history of NCT06229340 on ClinicalTrials.gov (opens the registry)
Changed